A National Quality Improvement Collaborative to Improve Antibiotic Use in Pediatric Infections.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
29 Apr 2024
Historique:
accepted: 03 10 2023
medline: 29 4 2024
pubmed: 29 4 2024
entrez: 29 4 2024
Statut: aheadofprint

Résumé

Nearly 25% of antibiotics prescribed to children are inappropriate or unnecessary, subjecting patients to avoidable adverse medication effects and cost. We conducted a quality improvement initiative across 118 hospitals participating in the American Academy of Pediatrics Value in Inpatient Pediatrics Network 2020 to 2022. We aimed to increase the proportion of children receiving appropriate: (1) empirical, (2) definitive, and (3) duration of antibiotic therapy for community-acquired pneumonia, skin and soft tissue infections, and urinary tract infections to ≥85% by Jan 1, 2022. Sites reviewed encounters of children >60 days old evaluated in the emergency department or hospital. Interventions included monthly audit with feedback, educational webinars, peer coaching, order sets, and a mobile app containing site-specific, antibiogram-based treatment recommendations. Sites submitted 18 months of baseline, 2-months washout, and 10 months intervention data. We performed interrupted time series (analyses for each measure. Sites reviewed 43 916 encounters (30 799 preintervention, 13 117 post). Overall median [interquartile range] adherence to empirical, definitive, and duration of antibiotic therapy was 67% [65% to 70%]; 74% [72% to 75%] and 61% [58% to 65%], respectively at baseline and was 72% [71% to 72%]; 79% [79% to 80%] and 71% [69% to 73%], respectively, during the intervention period. Interrupted time series revealed a 13% (95% confidence interval: 1% to 26%) intercept change at intervention for empirical therapy and a 1.1% (95% confidence interval: 0.4% to 1.9%) monthly increase in adherence per month for antibiotic duration above baseline rates. Balancing measures of care escalation and revisit or readmission did not increase. This multisite collaborative increased appropriate antibiotic use for community-acquired pneumonia, skin and soft tissue infections, and urinary tract infection among diverse hospitals.

Sections du résumé

BACKGROUND UNASSIGNED
Nearly 25% of antibiotics prescribed to children are inappropriate or unnecessary, subjecting patients to avoidable adverse medication effects and cost.
METHODS UNASSIGNED
We conducted a quality improvement initiative across 118 hospitals participating in the American Academy of Pediatrics Value in Inpatient Pediatrics Network 2020 to 2022. We aimed to increase the proportion of children receiving appropriate: (1) empirical, (2) definitive, and (3) duration of antibiotic therapy for community-acquired pneumonia, skin and soft tissue infections, and urinary tract infections to ≥85% by Jan 1, 2022. Sites reviewed encounters of children >60 days old evaluated in the emergency department or hospital. Interventions included monthly audit with feedback, educational webinars, peer coaching, order sets, and a mobile app containing site-specific, antibiogram-based treatment recommendations. Sites submitted 18 months of baseline, 2-months washout, and 10 months intervention data. We performed interrupted time series (analyses for each measure.
RESULTS UNASSIGNED
Sites reviewed 43 916 encounters (30 799 preintervention, 13 117 post). Overall median [interquartile range] adherence to empirical, definitive, and duration of antibiotic therapy was 67% [65% to 70%]; 74% [72% to 75%] and 61% [58% to 65%], respectively at baseline and was 72% [71% to 72%]; 79% [79% to 80%] and 71% [69% to 73%], respectively, during the intervention period. Interrupted time series revealed a 13% (95% confidence interval: 1% to 26%) intercept change at intervention for empirical therapy and a 1.1% (95% confidence interval: 0.4% to 1.9%) monthly increase in adherence per month for antibiotic duration above baseline rates. Balancing measures of care escalation and revisit or readmission did not increase.
CONCLUSIONS UNASSIGNED
This multisite collaborative increased appropriate antibiotic use for community-acquired pneumonia, skin and soft tissue infections, and urinary tract infection among diverse hospitals.

Identifiants

pubmed: 38682258
pii: 197166
doi: 10.1542/peds.2023-062246
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 by the American Academy of Pediatrics.

Déclaration de conflit d'intérêts

CONFLICT OF INTEREST DISCLOSURES: Drs Kerns and McCulloh share authorship rights to the software used to make the mobile decision support tool for this project, which was developed at the University of Nebraska Medical Center; Drs Kerns and McCulloh have funding from National Institutes of Health; Dr Newland has funding from Agency for Healthcare Research and Quality; and the remaining authors have no conflicts of interest relevant to this article to disclose.

Auteurs

Russell J McCulloh (RJ)

Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska.
Divisions of Pediatric Hospital Medicine.

Ellen Kerns (E)

Department of Pediatrics, University of Nebraska Medical Center, Omaha, Nebraska.
Care Transformation, Children's Nebraska, Omaha, Nebraska.

Ricky Flores (R)

Care Transformation, Children's Nebraska, Omaha, Nebraska.

Rachel Cane (R)

Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland.

Rana E El Feghaly (RE)

Divisions of Infectious Diseases.
Department of Pediatrics, University of Missouri Kansas City, Kansas City, Missouri.

Jennifer R Marin (JR)

Division of Pediatric Emergency Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Jessica L Markham (JL)

Pediatric Hospital Medicine, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri.
Department of Pediatrics, University of Missouri Kansas City, Kansas City, Missouri.

Jason G Newland (JG)

Department of Pediatrics, Washington University School of Medicine, Division of Pediatric Infectious Diseases, St Louis, Missouri.

Marie E Wang (ME)

Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California; and.

Matthew Garber (M)

Department of Pediatrics, University of Florida College of Medicine, Jacksonville, Florida.

Classifications MeSH